BSE Live
Nov 03, 16:01Prev. Close
1.56
Open Price
1.54
Bid Price (Qty.)
1.50 (1070382)
Offer Price (Qty.)
1.52 (34464)
NSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
| Balance Sheet of Remedium Lifecare (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 40.32 | 10.08 | 3.60 | 3.60 | 3.60 | |
| Total Share Capital | 40.32 | 10.08 | 3.60 | 3.60 | 3.60 | |
| Reserves and Surplus | 2.98 | 32.88 | 6.76 | 1.34 | 0.26 | |
| Total Reserves and Surplus | 2.98 | 32.88 | 6.76 | 1.34 | 0.26 | |
| Total Shareholders Funds | 43.30 | 42.96 | 10.36 | 4.94 | 3.86 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 10.50 | |
| Deferred Tax Liabilities [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Long Term Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Provisions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Non-Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 10.50 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 1,141.39 | 57.70 | 0.00 | 0.00 | 0.00 | |
| Trade Payables | 320.98 | 712.29 | 84.22 | 124.56 | 23.77 | |
| Other Current Liabilities | 31.72 | 1,134.98 | 1,057.13 | 93.79 | 0.25 | |
| Short Term Provisions | 2.26 | 0.00 | 2.51 | 0.47 | 0.15 | |
| Total Current Liabilities | 1,496.35 | 1,904.97 | 1,143.86 | 218.82 | 24.17 | |
| Total Capital And Liabilities | 1,539.65 | 1,947.92 | 1,154.22 | 223.76 | 38.53 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 0.01 | 0.05 | 0.08 | 0.09 | 0.07 | |
| Intangible Assets | 0.00 | 0.00 | 0.00 | 0.10 | 0.14 | |
| Capital Work-In-Progress | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 0.01 | 0.05 | 0.08 | 0.19 | 0.21 | |
| Non-Current Investments | 0.07 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax Assets [Net] | 0.04 | 0.03 | 0.01 | 0.00 | 0.00 | |
| Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Non-Current Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Non-Current Assets | 0.11 | 0.07 | 0.09 | 0.19 | 0.21 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventories | 269.38 | 133.23 | 7.32 | 83.87 | 3.11 | |
| Trade Receivables | 590.92 | 920.60 | 172.37 | 64.00 | 23.68 | |
| Cash And Cash Equivalents | 1.36 | 1.52 | 21.86 | 1.44 | 0.81 | |
| Short Term Loans And Advances | 675.38 | 890.38 | 952.01 | 74.11 | 10.17 | |
| OtherCurrentAssets | 2.50 | 2.11 | 0.58 | 0.16 | 0.55 | |
| Total Current Assets | 1,539.54 | 1,947.85 | 1,154.14 | 223.57 | 38.32 | |
| Total Assets | 1,539.65 | 1,947.92 | 1,154.22 | 223.76 | 38.53 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 0.00 | 0.00 | 0.00 | 51.03 | 0.00 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 0.00 | 2,768.08 | 1,200.59 | 0.00 | 0.03 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | -- | -- | -- | -- | -- | |
| Other Earnings | -- | -- | 113.65 | 44.01 | 0.70 | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | -- | -- | -- | -- | -- | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | -- | -- | -- | -- | -- | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- | -- | -- | -- | 
05.08.2025
Remedium Lifeca Standalone June 2025 Net Sales at Rs 18.37 crore, down 76.35% Y-o-Y
24.06.2025
Remedium Lifeca Standalone March 2025 Net Sales at Rs 81.57 crore, down 94.21% Y-o-Y
26.11.2024
Remedium Lifeca Standalone September 2024 Net Sales at Rs 25.08 crore, down 94.65% Y-o-Y
19.08.2024
Remedium Lifeca Standalone June 2024 Net Sales at Rs 77.70 crore, down 76.49% Y-o-Y
05.08.2025
Remedium Lifeca Standalone June 2025 Net Sales at Rs 18.37 crore, down 76.35% Y-o-Y
24.06.2025
Remedium Lifeca Standalone March 2025 Net Sales at Rs 81.57 crore, down 94.21% Y-o-Y
26.11.2024
Remedium Lifeca Standalone September 2024 Net Sales at Rs 25.08 crore, down 94.65% Y-o-Y
19.08.2024
Remedium Lifeca Standalone June 2024 Net Sales at Rs 77.70 crore, down 76.49% Y-o-Y
15.02.2017
15.02.2017
14.02.2017
13.02.2017